+ Watch NVAX
on My Watchlist
A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
NVAX has new homogenate to make its patented Viral Like Particles that uses insect homogenate v eggs. (Currently takes about a billion eggs/yr to make our flu vaccine) Factories are much cheaper to build. The hysteresis from virus to vaccine is half the time of conventional vaccines. They have an RSV vaccine that appears to be very immunogenic. (The only one out there right now)
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions